Photo-induced Structural Changes in Polyolefin-nanoclay Composite

The morphology of films prepared by melt-blending polyethylene (PE) and polypropylene (PP) withand without nanoclay was investigated after exposure to outdoor solar radiations for 45 days utilising manytechniques. The Raman spectra revealed decreased intensity for all the characteristic Raman bands for PP andPE. The Fourier transform infrared spectroscopy showed formation of hydroxyl/hydroperoxy and carbonylgroups in the exposed samples. The weathered films after 45 days of solar exposure became brittle as indicatedby loss in physical properties and the stress-strain curves. The clay-containing films showed higher strengthloss after solar exposure. The fractured ends of the exposed films showed flat, smooth, and sharp surfaces,indicative of brittle fracture, compared to the unexposed sample.Defence Science Journal, 2008, 58(6), pp.778-784, DOI:http://dx.doi.org/10.14429/dsj.58.170

Current scenario and challenges for bone retrieval for allograft use in North India

Bone grafts are the second most common tissue transplanted. With advances in the treatment of musculoskeletal tumors, limb salvage surgery, with its concomitant demand for bone graft, has increased significantly. This study aims to evaluate current scenario for bone donation in north India. This study was done in bone bank, Government Medical College, Kota, Rajasthan. Inclusion and exclusion criteria of bone donors were followed as per the APASTB standards of tissue banking. Bone was retrieved from deceased donor and live donors after proper consent and counselling in this institute during period 01 January 2021 to 31 January 2022. During the period of study bones were retrieved from 26 donors – 24 live donors and 2 cadavers. Out of 24 live donors 20 were femoral head, 2 tibia and fibula and 2 hemi-radius and hemi-ulna. All donors were between 28-71-year age group and mean age was 56 years. 18 males and 8 females participated in study. There is huge difference between demand and supply of bone allograft in this region of country. There is lack of initiative from government for encouraging people to donate bone along with other organ and tissue donations. Lack of infrastructure for to and fro transport of bone retrieval from deceased and live donors to storage unit results in loss of bone samples. Less trained personnel and sufficiently low coordination between various institutes. Concerns of family members and misconceptions to be addressed properly to reduce morbidity burden in society

Metagenomics Analysis of Thrombus Samples Retrieved from Mechanical Thrombectomy

Purpose The purpose of this study was to assess the microbiota in middle cerebral artery thrombi retrieved in mechanical thrombectomy arising out of symptomatic carotid plaque within 6 hours of acute ischemic stroke. Thrombi were subjected to next-generation sequencing for a bacterial signature to determine their role in atherosclerosis. Materials and Methods We included 4 human middle cerebral artery thrombus samples (all patients were male). The median age for the patients was 51±13.6 years. Patients enrolled in the study from Pacific Medical University and Hospital underwent mechanical thrombectomy in the stroke window period. All patients underwent brain magnetic resonance angiography (MRA) and circle of Willis and neck vessel MRA along with the standard stroke workup to establish stroke etiology. Only patients with symptomatic carotid stenosis and tandem lesions with ipsilateral middle cerebral artery occlusion were included in the study. Thrombus samples were collected, stored at –80 degrees, and subjected to metagenomics analysis. Results Of the 4 patients undergoing thrombectomy for diagnosis with ischemic stroke, all thrombi recovered for bacterial DNA in qPCR were positive. More than 27 bacteria were present in the 4 thrombus samples. The majority of bacteria were Lactobacillus, Stenotrophomonas, Pseudomonas, Staphylococcus, and Finegoldia. Conclusion Genesis of symptomatic atherosclerotic carotid plaque leading to thromboembolism could be either due to direct mechanisms like acidification and local inflammation of plaque milieu with lactobacillus, biofilm dispersion leading to inflammation like with pseudomonas fluorescence, or enterococci or indirect mechanisms like Toll 2 like signaling by gut microbiota

Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and Pegiviruses

To investigate the transmission of novel infectious agents by blood transfusion, we studied changes in the virome composition of blood transfusion recipients pre- and posttransfusion. Using this approach, we detected and genetically characterized a novel human virus, human hepegivirus 1 (HHpgV-1), that shares features with hepatitis C virus (HCV) and human pegivirus (HPgV; formerly called GB virus C or hepatitis G virus). HCV and HPgV belong to the genera Hepacivirus and Pegivirus of the family Flaviviridae. HHpgV-1 was found in serum samples from two blood transfusion recipients and two hemophilia patients who had received plasma-derived clotting factor concentrates. In the former, the virus was detected only in the posttransfusion samples, indicating blood-borne transmission. Both hemophiliacs were persistently viremic over periods of at least 201 and 1,981 days. The 5′ untranslated region (UTR) of HHpgV-1 contained a type IV internal ribosome entry site (IRES), structurally similar to although highly divergent in sequence from that of HCV and other hepaciviruses. However, phylogenetic analysis of nonstructural genes (NS3 and NS5B) showed that HHpgV-1 forms a branch within the pegivirus clade distinct from HPgV and homologs infecting other mammalian species. In common with some pegivirus variants infecting rodents and bats, the HHpgV-1 genome encodes a short, highly basic protein upstream of E1, potentially possessing a core-like function in packaging RNA during assembly. Identification of this new human virus, HHpgV-1, expands our knowledge of the range of genome configurations of these viruses and may lead to a reevaluation of the original criteria by which the genera Hepacivirus and Pegivirus are defined

Modelling stock market performance of firms as a function of the quality and quantity of intellectual property owned

This thesis attempts to analyze a part of the big and complex process of how intellectual property ownership and technological innovation influence the performance of firms and their revenues. Here I analyze a firm's stock market performance as a function of the quantity and quality of intellectual property (patents) owned by the firm in context of the three US high-technology sectors, Pharmaceuticals, Semiconductors and Wireless. In these sectors, value of a firm is predominantly driven by the technologies which a firm owns. I use citation based indicators and number of claims to measure the quality of patents. This research presents empirical evidence for the hypothesis that in high-tech sectors, companies which generate better quality intellectual property perform better than average in the stock market. I also posit that firms which are producing better quality technologies (good R&D) invest more in R&D regardless of their market performance. Furthermore, though smaller firms get relatively less returns on quality and quantity of innovation, they tend to invest a bigger fraction of their total assets in R&D when they are generating high quality patents. Larger firms enjoy the super-additivity effects in terms of market performance as the same intellectual property gives better returns to them. In addition, returns to R&D are relatively higher in the pharmaceutical industry than semiconductor or wireless industries.M.S.Committee Chair: Hicks, Diana; Committee Co-Chair: Rouse, Bill; Committee Member: Bodner, Dougla

Agnikarma - Understanding the process from Past to the Present

Throughout human history, medical practices have evolved and adapted to the prevailing knowledge, culture, and technology of their time. One such ancient medical technique that holds a significant place in history is "Agnikarma," a fire-based therapeutic intervention. Originating in civilizations such as India, China, Greece, and Egypt, Agnikarma's evolution and significance are explored within their cultural and medical contexts. Its origins are traced to ancient medical texts, including the "Sushruta Samhita" and the "Huangdi Neijing," which document its application in Ayurvedic and Traditional Chinese Medicine (TCM), respectively. Agnikarma's role in treating a wide array of conditions, from pain relief to chronic ailments, is examined, reflecting its diverse applications across cultures. Agnikarma involves the application of heat to specific points on the body using a variety of instruments, such as metal rods, needles, and cow dung cakes. By stimulating blood circulation and promoting the body's natural healing process, Agnikarma has been used to address conditions ranging from musculoskeletal pain to skin disorders. An attempt is made using this article to review how the process started from being worshipped like God to a therapeutic procedure, the step-by-step development. This review article explores the historical origins and contemporary use of Agnikarma therapy. The article also discusses the future directions for the research and development of this ancient healing technique. In essence, this historical review illuminates Agnikarma's cultural significance, medical impact, and role in shaping the trajectory of medical practices through time

A potential role for SARS-CoV-2 small viral RNAs in targeting host microRNAs and modulating gene expression.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease (COVID-19) in humans, with symptoms ranging from mild to severe, including fatality. The molecular mechanisms surrounding the effects of viral infection on the host RNA machinery remain poorly characterized. We used a comparative transcriptomics approach to investigate the effects of SARS-CoV-2 infection on the host mRNA and sRNA expression machinery in a human lung epithelial cell line (Calu-3) and an African green monkey kidney cell line (Vero-E6). Upon infection, we observed global changes in host gene expression and differential expression of dozens of host miRNAs, many with known links to viral infection and immune response. Additionally, we discovered an expanded landscape of more than a hundred SARS-CoV-2-derived small viral RNAs (svRNAs) predicted to interact with differentially expressed host mRNAs and miRNAs. svRNAs are derived from distinct regions of the viral genome and sequence signatures suggest they are produced by a non-canonical biogenesis pathway. 52 of the 67 svRNAs identified in Calu-3 cells are predicted to interact with differentially expressed miRNAs, with many svRNAs having multiple targets. Accordingly, we speculate that these svRNAs may play a role in SARS-CoV-2 propagation by modulating post-transcriptional gene regulation, and that methods for antagonizing them may have therapeutic value

A Short Series of Case Reports of COVID-19 in Immunocompromised Patients

Immunocompromised individuals are at risk of prolonged SARS-CoV-2 infection due to weaker immunity, co-morbidities, and lowered vaccine effectiveness, which may evolve highly mutated variants of SARS-CoV-2. Nonetheless, limited data are available on the immune responses elicited by SARS-CoV-2 infection, reinfections, and vaccinations with emerging variants in immunocompromised patients. We analyzed clinical samples that were opportunistically collected from eight immunocompromised individuals for mutations in SARS-CoV-2 genomes, neutralizing antibody (NAb) titers against different SARS-CoV-2 variants, and the identification of immunoreactive epitopes using a high-throughput coronavirus peptide array. The viral genome analysis revealed two SARS-CoV-2 variants (20A from a deceased patient and an Alpha variant from a recovered patient) with an eight amino-acid (aa) deletion within the N-terminal domain (NTD) of the surface glycoprotein. A higher NAb titer was present against the prototypic USA/WA1/2020 strain in vaccinated immunocompromised patients. NAb titer was absent against the Omicron variant and the cultured virus of the 20A variant with eight aa deletions in non-vaccinated patients. Our data suggest that fatal SARS-CoV-2 infections may occur in immunocompromised individuals even with high titers of NAb post-vaccination. Moreover, persistent SARS-CoV-2 infection may lead to the emergence of newer variants with additional mutations favoring the survival and fitness of the pathogen that include deletions in NAb binding sites in the SARS-CoV-2 surface glycoprotein

Identification of immunoreactive linear epitopes of Borrelia miyamotoi.

Borrelia miyamotoi is an emerging tick-borne spirochete transmitted by ixodid ticks. Current serologic assays for B. miyamotoi are impacted by genetic similarities to other Borrelia and limited understanding of optimal antigenic targets. In this study, we employed the TBD-Serochip, a peptide array platform, to identify new linear targets for serologic detection of B. miyamotoi. We examined a wide range of suspected B. miyamotoi antigens and identified 352 IgM and 91 IgG reactive peptides, with the majority mapping to variable membrane proteins. These included peptides within conserved fragments of variable membrane proteins that may have greater potential for differential diagnosis. We also identified reactive regions on FlaB, and demonstrate crossreactivity of B. burgdorferi s.l. C6 with a B. miyamotoi C6-like peptide. The panel of linear peptides identified in this study can be used to enhance serodiagnosis of B. miyamotoi

BacCapSeq: a Platform for Diagnosis and Characterization of Bacterial Infections

BacCapSeq is a method for differential diagnosis of bacterial infections and defining antimicrobial sensitivity profiles that has the potential to reduce morbidity and mortality, health care costs, and the inappropriate use of antibiotics that contributes to the development of antimicrobial resistance.We report a platform that increases the sensitivity of high-throughput sequencing for detection and characterization of bacteria, virulence determinants, and antimicrobial resistance (AMR) genes. The system uses a probe set comprised of 4.2 million oligonucleotides based on the Pathosystems Resource Integration Center (PATRIC) database, the Comprehensive Antibiotic Resistance Database (CARD), and the Virulence Factor Database (VFDB), representing 307 bacterial species that include all known human-pathogenic species, known antimicrobial resistance genes, and known virulence factors, respectively. The use of bacterial capture sequencing (BacCapSeq) resulted in an up to 1,000-fold increase in bacterial reads from blood samples and lowered the limit of detection by 1 to 2 orders of magnitude compared to conventional unbiased high-throughput sequencing, down to a level comparable to that of agent-specific real-time PCR with as few as 5 million total reads generated per sample. It detected not only the presence of AMR genes but also biomarkers for AMR that included both constitutive and differentially expressed transcripts